Literature DB >> 33513855

Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center.

Richard E Evenhuis1, Ibtissam Acem1,2, Anja J Rueten-Budde3, Diederik S A Karis1, Marta Fiocco3, Desiree M J Dorleijn1, Frank M Speetjens4, Jakob Anninga5, Hans Gelderblom4, Michiel A J van de Sande1,5.   

Abstract

Age is a known prognostic factor for many sarcoma subtypes, however in the literature there are limited data on the different risk profiles of different age groups for osteosarcoma survival. This study aims to provide an overview of survival in patients with high-grade osteosarcoma in different age groups and prognostic variables for survival and local control among the entire cohort. In this single center retrospective cohort study, 402 patients with skeletal high-grade osteosarcoma were diagnosed and treated with curative intent between 1978 and 2017 at the Leiden University Medical Center (LUMC). Prognostic factors for survival were analyzed using a Cox proportional hazard model. In this study poor overall survival (OS) and event-free survival (EFS) were associated with increasing age. Age groups, tumor size, poor histopathological response, distant metastasis (DM) at presentation and local recurrence (LR) were important independent prognostic factors influencing OS and EFS. Differences in outcome among different age groups can be partially explained by patient and treatment characteristics.

Entities:  

Keywords:  age groups; chemotherapy; local recurrence; metastasis; osteosarcoma; prognosis; survival

Year:  2021        PMID: 33513855     DOI: 10.3390/cancers13030486

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  3 in total

1.  Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study.

Authors:  Toshihide Hirai; Hiroshi Kobayashi; Eisuke Kobayashi; Masanori Saito; Toru Akiyama; Kazutaka Kikuta; Takaaki Nakai; Makoto Endo; Shinji Tsukamoto; Michiyuki Hakozaki; Satoshi Takenaka; Shunji Nishimura; Hiroyuki Kawashima; Yoshikazu Tanzawa; Hirotaka Kawano; Sakae Tanaka
Journal:  Int J Clin Oncol       Date:  2022-08-06       Impact factor: 3.850

2.  Biology and technology in the surgical treatment of malignant bone tumours in children and adolescents, with a special note on the very young.

Authors:  Lizz van der Heijden; Germán L Farfalli; Inês Balacó; Cristina Alves; Marta Salom; José M Lamo-Espinosa; Mikel San-Julián; Michiel A J van de Sande
Journal:  J Child Orthop       Date:  2021-08-20       Impact factor: 1.548

3.  Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.

Authors:  Bo Chen; Yuan Zeng; Bo Liu; Gaoxiang Lu; Zhouxia Xiang; Jiyang Chen; Yan Yu; Ziyi Zuo; Yangjun Lin; Jinfeng Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.